685 related articles for article (PubMed ID: 10455056)
21. Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.
Dikov MM; Oyama T; Cheng P; Takahashi T; Takahashi K; Sepetavec T; Edwards B; Adachi Y; Nadaf S; Daniel T; Gabrilovich DI; Carbone DP
Cancer Res; 2001 Mar; 61(5):2015-21. PubMed ID: 11280761
[TBL] [Abstract][Full Text] [Related]
22. CYP2J2 and EETs Protect against Oxidative Stress and Apoptosis in Vivo and in Vitro Following Lung Ischemia/Reperfusion.
Chen W; Zheng G; Yang S; Ping W; Fu X; Zhang N; Wang DW; Wang J
Cell Physiol Biochem; 2014; 33(6):1663-80. PubMed ID: 24903033
[TBL] [Abstract][Full Text] [Related]
23. Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation.
Loot AE; Popp R; Fisslthaler B; Vriens J; Nilius B; Fleming I
Cardiovasc Res; 2008 Dec; 80(3):445-52. PubMed ID: 18682435
[TBL] [Abstract][Full Text] [Related]
24. ZLJ-6, a novel COX/5-LOX inhibitor, attenuates TNF-α-induced endothelial E-selectin, ICAM-1 and VCAM-1 expression and monocyte-endothelial interactions via a COX/5-LOX-independent mechanism.
Chen L; Zhao Q; Wang XL; You R; Zhang YH; Ji H; Lai YS
Vascul Pharmacol; 2011; 55(5-6):135-42. PubMed ID: 21777697
[TBL] [Abstract][Full Text] [Related]
25. Cyclic stretch enhances the expression and activity of coronary endothelium-derived hyperpolarizing factor synthase.
Fisslthaler B; Popp R; Michaelis UR; Kiss L; Fleming I; Busse R
Hypertension; 2001 Dec; 38(6):1427-32. PubMed ID: 11751730
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA
PLoS One; 2017; 12(3):e0174137. PubMed ID: 28328948
[TBL] [Abstract][Full Text] [Related]
27. 11,12-Epoxyecosatrienoic acids mitigate endothelial dysfunction associated with estrogen loss and aging: Role of membrane depolarization.
Sun C; Simon SI; Foster GA; Radecke CE; Hwang HV; Zhang X; Hammock BD; Chiamvimonvat N; Knowlton AA
J Mol Cell Cardiol; 2016 May; 94():180-188. PubMed ID: 27079253
[TBL] [Abstract][Full Text] [Related]
28. Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids.
Krötz F; Riexinger T; Buerkle MA; Nithipatikom K; Gloe T; Sohn HY; Campbell WB; Pohl U
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):595-600. PubMed ID: 14715644
[TBL] [Abstract][Full Text] [Related]
29. A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity.
Ziegelbauer K; Gantner F; Lukacs NW; Berlin A; Fuchikami K; Niki T; Sakai K; Inbe H; Takeshita K; Ishimori M; Komura H; Murata T; Lowinger T; Bacon KB
Br J Pharmacol; 2005 May; 145(2):178-92. PubMed ID: 15753951
[TBL] [Abstract][Full Text] [Related]
30. Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-α-induced injury.
Zhao G; Wang J; Xu X; Jing Y; Tu L; Li X; Chen C; Cianflone K; Wang P; Dackor RT; Zeldin DC; Wang DW
J Lipid Res; 2012 Mar; 53(3):456-466. PubMed ID: 22223859
[TBL] [Abstract][Full Text] [Related]
31. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
Spiecker M; Darius H; Hankeln T; Soufi M; Sattler AM; Schaefer JR; Node K; Börgel J; Mügge A; Lindpaintner K; Huesing A; Maisch B; Zeldin DC; Liao JK
Circulation; 2004 Oct; 110(15):2132-6. PubMed ID: 15466638
[TBL] [Abstract][Full Text] [Related]
32. Epoxyeicosatrienoic acids, cell signaling and angiogenesis.
Fleming I
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):60-7. PubMed ID: 17164133
[TBL] [Abstract][Full Text] [Related]
33. Role of cytochrome P450 2C epoxygenases in hypoxia-induced cell migration and angiogenesis in retinal endothelial cells.
Michaelis UR; Xia N; Barbosa-Sicard E; Falck JR; Fleming I
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1242-7. PubMed ID: 18326754
[TBL] [Abstract][Full Text] [Related]
34. Piperine inhibits TNF-alpha induced adhesion of neutrophils to endothelial monolayer through suppression of NF-kappaB and IkappaB kinase activation.
Kumar S; Singhal V; Roshan R; Sharma A; Rembhotkar GW; Ghosh B
Eur J Pharmacol; 2007 Dec; 575(1-3):177-86. PubMed ID: 17764673
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of aldose reductase attenuates TNF-alpha-induced expression of adhesion molecules in endothelial cells.
Ramana KV; Bhatnagar A; Srivastava SK
FASEB J; 2004 Aug; 18(11):1209-18. PubMed ID: 15284221
[TBL] [Abstract][Full Text] [Related]
36. Cerebral capillary endothelial cell mitogenesis and morphogenesis induced by astrocytic epoxyeicosatrienoic Acid.
Zhang C; Harder DR
Stroke; 2002 Dec; 33(12):2957-64. PubMed ID: 12468797
[TBL] [Abstract][Full Text] [Related]
37. Cytochrome P450 2C is an EDHF synthase in coronary arteries.
Fisslthaler B; Popp R; Kiss L; Potente M; Harder DR; Fleming I; Busse R
Nature; 1999 Sep; 401(6752):493-7. PubMed ID: 10519554
[TBL] [Abstract][Full Text] [Related]
38. TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells.
Min JK; Kim YM; Kim SW; Kwon MC; Kong YY; Hwang IK; Won MH; Rho J; Kwon YG
J Immunol; 2005 Jul; 175(1):531-40. PubMed ID: 15972689
[TBL] [Abstract][Full Text] [Related]
39. Epoxyeicosatrienoic acids regulate macrophage polarization and prevent LPS-induced cardiac dysfunction.
Dai M; Wu L; He Z; Zhang S; Chen C; Xu X; Wang P; Gruzdev A; Zeldin DC; Wang DW
J Cell Physiol; 2015 Sep; 230(9):2108-19. PubMed ID: 25626689
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of hydroxyeicosatetraenoic (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells.
Rosolowsky M; Campbell WB
Biochim Biophys Acta; 1996 Jan; 1299(2):267-77. PubMed ID: 8555273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
